Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nutra Pharma Corp NPHC

Healthcare Biotechnology
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer... see more

Recent & Breaking News (GREY:NPHC)

Nutra Pharma Corp. Reaches Settlement with SEC

GlobeNewswire March 22, 2024

Nutra Pharma Announces First Manufacturing Agreement

GlobeNewswire March 23, 2022

Nutra Pharma Expands Manufacturing Capabilities

GlobeNewswire March 17, 2022

Nutra Pharma Letter to Shareholders

GlobeNewswire January 18, 2022

Nutra Pharma Provides Business and Compliance Updates

GlobeNewswire July 26, 2021

Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures

GlobeNewswire July 23, 2021

Nutra Pharma Engages Government Affairs Consulting Firm

GlobeNewswire July 15, 2021

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Newsfile June 8, 2021

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Newsfile June 4, 2021

Professional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain Relief

Newsfile June 2, 2021

Nutra Pharma Provides Updates on Improvements of Manufacturing Capabilities

Newsfile May 27, 2021

Nutra Pharma Announces Influencer and Social Media Campaign for Nyloxin and Pet Pain-Away

Newsfile May 24, 2021

Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

Newsfile April 15, 2021

Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels

Newsfile March 16, 2021

Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials

Newsfile March 11, 2021

Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications

Newsfile February 23, 2021

Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys

Newsfile February 12, 2021

Nutra Pharma Letter to Shareholders

Newsfile January 12, 2021

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

Newsfile November 18, 2020

Nutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace

Newsfile November 11, 2020